Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44020351HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44033383HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44017263HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44012250HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44046578HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TCGA Plot Options
Drug Information
GeneGUCY1A2
DrugBank IDDB01020
Drug NameIsosorbide mononitrate
Target IDBE0003578
UniProt IDP33402
Regulation Typeactivator
PubMed IDs1852778; 20089135; 25446162
CitationsMoncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109-42.@@Mancuso C, Navarra P, Preziosi P: Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. J Neurochem. 2010 May;113(3):563-75. doi: 10.1111/j.1471-4159.2010.06606.x. Epub 2010 Jan 20.@@Munzel T, Steven S, Daiber A: Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction. Vascul Pharmacol. 2014 Dec;63(3):105-13. doi: 10.1016/j.vph.2014.09.002. Epub 2014 Oct 14.
GroupsApproved
Direct ClassificationIsosorbides
SMILES[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O
Pathways
PharmGKBPA450126
ChEMBLCHEMBL1311